Health Condition 1: null- Acute diarrhea Health Condition 2: R197- Diarrhea, unspecified
Conditions
Interventions
Intervention1: Saccharomyces boulardii, Bacillus coagulans and Bacillus clausii: 1 Capsule two times a day before meals for 10 days
Control Intervention1: Nil: Nil
Sponsors
Unique Biotech Limited
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adults with acute diarrhoea having > 3 loose stools in last 24 hours, having diarrhoea 2. Patients with no major illness. 3. Patients willing to give written informed Consent & willing to follow up.
Exclusion criteria
Exclusion criteria: 1. Mucous stools or bleeding per rectum 2. Subjects taking any other medications like anticoagulants, beta-blockers, diuretics, and steroids etc., which have potential effects on lipoprotein regulation mechanisms. 3. Subjects with the recent history of cardiovascular diseases like MI or who have undergone angioplasties, coronary bypass surgery or any other documented morbidity from atherosclerotic vascular diseases within the last 6 months of enrollment. 4. Subjects with past history of any debilitating neurological disorders, severe depression. 5. Clinical signs of severe dehydration, clinical signs of coexisting acute systemic illnesses (meningitis, sepsis, pneumonia), immunodeficiency, underlying severe chronic diseases, cystic fibrosis, 6. Food allergy or other chronic gastrointestinal diseases, 7. Use of probiotics in the previous three weeks, use of antibiotics or any antidiarrhoeal medication in the previous three weeks.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Duration of Diarrhea 2. Frequency of Diarrhea Timepoint: 10 days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Rescue medication 2. Safety Assessment 3. Clinical Global Assessment by Investigator on liken scale 4. Patients Self Assessment Timepoint: 10 days | — |
Countries
India
Contacts
Public ContactMr Bharat Shukla
Outcome results
None listed